Top Stories
HBF Researchers Develop Blood Test for Liver Damage
Oct. 17 - Hepatitis B Foundation scientists are developing a simple blood test that can help identify people with liver disease by detecting an antibody that is present in people with liver damage. View Video.
Genetic 'Fingerprint' Shown To Predict Liver Cancer's Return
Oct. 17 - Scientists have reached a critical milestone in the study of liver cancer that lays the groundwork for predicting the illness's path, whether toward cure or recurrence. Read Full Article.
Vitamin D Deficiency Common in Patients with Chronic Liver Disease
Oct. 17 - A research study of 118 chronic liver disease patients found that 92.4 percent had some degree of vitamin D deficiency and at least one third were severely deficient.. Read Full Article.
HBF Happenings
Fall Newsletter Correction: FDA Approved Viread is from Gilead
September 25 - The Fall 2008 B Informed newsletter Drug Watch (p. 4) includes an error regarding the new FDA-approved drug Viread (tenofovir), which is from Gilead Sciences.
The Severity of Hepatitis B in Asian Communities
Thursday November 6, 2008
8:30 – 1:00 pm
Temple University, Philadelphia
A free conference for health and outreach professionals serving the Asian community to learn about the burden of hepatitis B and liver cancer among Asians in Philadelphia, PA. Breakfast and lunch included. Registration limited to 100, so Register Online today!
Hepatitis B Foundation STEERS Students through Summer Enrichment Programs
September 10 - The Hepatitis B Foundation offers a unique experience in professional research labs to prepare high school, college, and graduate students for potential careers in the fast-growing areas of biomedical research, biotechnology, and public health research.
| 
